#GLP1 #BehaviourChange #Physiotherapy #LifestyleMedicine #WorkplaceWellbeing #MusculoskeletalHealth Interesting findings from a new economic study suggest that workers taking GLP-1 weight loss medications may experience fewer sick days
If you are taking a related licensed medicine such as semaglutide (Ozempic or Wegovy) or tirzepatide (Mounjaro), which act on overlapping receptor pathways and are experiencing nausea, it is entirely appropriate to discuss this with your GP or prescriber
Rest assured that your health, safety, and weight loss goals are our number one priority
Key Definitions Baseline heart rate was defined as the average of all heart rate measurements for each patient before receiving the first randomized study medication
Understanding Wegovy Wegovy is an FDA-approved injectable form of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist
It helps the body move through the final stages of healing, rather than remaining stuck in a prolonged state of inflammation or partial repair